Explore life science companies operating throughout South East England, including biotechnology firms, CROs and research organisations.
Non-viral intracellular drug delivery for solid tumours
Vitarka Therapeutics is a preclinical biotech company developing a non-viral drug delivery platform for targeted intracellular delivery of therapeutics to solid tumours. The technology uses pore-forming proteins to transport RNAi therapies and other payloads directly into cancer cells while limiting off-target…
Bioinformatics, software and compliance consultancy for biotech companies
Prismea is a provider of bioinformatics, software and cloud consultancy services for biotechnology companies. The company supports biotech clients with data analysis across genomics, imaging, spectroscopy, epidemiology and metabolomics, alongside custom software development, cloud infrastructure management and…
Spirometry devices and respiratory endpoint services for clinical trials
Vitalograph develops respiratory diagnostic equipment, including spirometers and pulmonary function testing systems used in healthcare, occupational health and research. The company also provides clinical trial services, with centralised collection of lung function and cardiac safety endpoint data. These services…
RNA-targeted drug discovery platform using machine learning
RevoNA Bio is a biotechnology company developing a high-throughput RNA biological platform for RNA-targeted drug discovery. The platform generates comprehensive RNA structural and functional datasets that feed a machine learning predictive engine, supporting hit identification, structure-activity relationship…
Biological sample processing and storage services
UK Biocentre is a contract service provider specialising in large-scale biological sample management, processing, and automated cold storage for biomedical, pharmaceutical and clinical research. Established as the commercial service arm of UK Biobank, the company operates a 70,000 square-foot facility in Milton Keynes…
PET radiopharmaceutical diagnostics for cancer imaging
Blue Earth Diagnostics Limited is a molecular imaging company developing and commercialising PET radiopharmaceuticals for cancer diagnosis and treatment planning. The company serves clinicians, healthcare systems and patients by providing administered imaging agents that support clinical decision making in oncology.…
Global pharma company in oncology, immunology, and neuroscience
Johnson & Johnson is a multinational pharmaceutical company with UK operations spanning commercial, medical affairs, and innovation activities. Its Innovative Medicine division covers oncology, immunology, neuroscience, and infectious disease. The company operates an EMEA Innovation Centre in London focused on…
Confocal ophthalmoscope for preclinical retinal imaging in small animals
Vox Imaging Technology is a UK-based developer of laboratory imaging instruments for preclinical eye research. The company's benchtop confocal Scanning Laser Ophthalmoscope is designed for retinal imaging in small animals, built to overcome limitations of existing research instruments identified through consultation…
Biotech venture builder co-creating and scaling drug discovery companies
Molecule to Medicine (MTM) is a biotech venture builder that co-creates, builds, and scales drug discovery companies within a shared operational ecosystem, combining drug discovery expertise with shared infrastructure to enable rapid company formation. UK operations are based at Milton Park, Abingdon, with a further…
Antimicrobial and biocompatible surface coatings for orthopaedic implants
Accentus Medical is a surface engineering company developing and applying biocompatible and antimicrobial coatings for implantable medical devices, particularly orthopaedic implants. Its technologies include plasma-sprayed titanium and hydroxyapatite coatings that support bone integration, and silver-ion surface…
Clinical research organisation offering trial delivery and functional outsourcing services
Advanced Clinical is a clinical research organisation supporting biopharmaceutical and medical device companies through full-service and functional service provider models. It provides clinical trial management, site monitoring, quality and validation services and strategic resourcing, placing specialist clinical…
Analytical testing, development and training for pharma and food sectors
Reading Scientific Services (RSSL) is a contract research organisation based at the University of Reading, providing analytical testing, product development, consultancy and training to pharmaceutical, biopharmaceutical and food and consumer goods companies. Its GMP and ISO 17025-accredited laboratories offer…
Contactless respiratory monitoring and digital biomarkers for clinical trials
Albus Health is a clinical research technology company developing passive, contactless monitoring for respiratory studies and pharmaceutical trials. Its bedside Albus Home system combines acoustic and other sensors to measure nocturnal cough, breathing and environmental conditions without requiring patients to wear…
Full-service CRO for Phase I–IV pharmaceutical and device trials
Clinicology is a contract research organisation providing clinical trial management services to pharmaceutical, biotechnology, and medical device companies. Services span site startup, monitoring, project management, regulatory submissions, patient recruitment, medical monitoring, medical writing, and…
Small molecule therapies for cystic fibrosis and COPD
Enterprise Therapeutics is a clinical-stage biopharmaceutical company developing novel muco-regulatory therapies for respiratory diseases. Its lead programme ETD001 is a first-in-class inhaled ENaC blocker designed to hydrate airway mucus and improve mucociliary clearance, currently in a Phase 2a trial in cystic…
CSF-1R antibody therapy for tenosynovial giant cell tumour
SynOx Therapeutics is a late-stage biopharmaceutical company developing emactuzumab, a humanised monoclonal antibody targeting CSF-1R, for the treatment of tenosynovial giant cell tumour and other macrophage-driven conditions. Emactuzumab was licensed from Roche and inhibits the CSF-1 receptor to deplete…
Cancer immunotherapies targeting novel antigens from the dark genome
Enara Bio is a clinical-stage biopharmaceutical company developing cancer immunotherapies directed against Dark Antigens, a class of cancer-specific targets derived from previously uncharted genomic dark matter. Its platform integrates bioinformatics, immunopeptidomics, and immunology to discover and validate novel…
Specialist CRO for drug and agrochemical metabolite synthesis and characterisation
Hypha Discovery is a specialist contract research organisation supporting pharmaceutical and agrochemical companies worldwide. The company produces and purifies drug and agrochemical metabolites using microbial biotransformation, recombinant enzyme systems and late-stage chemical synthesis, supporting metabolite…
Science and innovation campus in Oxford's Cowley district
ARC Oxford is an 88-acre science and innovation campus located in Cowley, Oxford, operating as part of the Advanced Research Clusters network owned by Brookfield. Formerly Oxford Business Park, it was relaunched under the ARC brand in September 2022. The campus hosts over 35 organisations including a growing number of…
Small molecule GPR65 inhibitors restoring immune response in solid tumours
Pathios Therapeutics is a clinical-stage drug discovery company developing small molecule inhibitors of GPR65, a pH-sensing G protein-coupled receptor that drives immunosuppressive polarisation of tumour-associated macrophages in the acidic tumour microenvironment. By blocking GPR65, Pathios aims to restore…